Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of KW-0761 in Relapsed CCR4-Positive Adult T-cell Leukemia-Lymphoma
NCT00920790Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Jun 2009
- Primary completion
- Jul 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mogamulizumab in adult T-cell leukemia-lymphoma (ATLL), sponsored by Kyowa Kirin. Started Jun 2009; status: completed.
02
Drugs
mogamulizumab
03
Conditions
adult T-cell leukemia-lymphoma (ATLL)
Beyond the preview
Go deeper on NCT00920790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920790.